Novartis AG to Discuss Zolgensma® MDA Data Call Transcript
Good morning and good afternoon, and welcome to the Zolgensma MDA Data Investor Call. (Operator Instructions) And the conference is being recorded. (Operator Instructions)
With that, I would like to hand over to Mr. Samir Shah, Global Head of Investor Relations. Please go ahead, sir.
Thank you very much for -- to everybody for joining us today. And our sincere apologies for the technical difficulties in getting through and registering for the call. We wanted to provide you with an update on several recent important AveXis-related data and regulatory milestones.
Before we start, I'll read the safe harbor statement. The information presented in this conference call contains forward-looking statements that involve known and unknown risks, uncertainties and other factors. These may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. Please refer to the company's press releases and Form 20-F on file with the U.S.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
